[HTML][HTML] Update in lean metabolic dysfunction-associated steatotic liver disease

K Sato-Espinoza, P Chotiprasidhi… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND A new nomenclature consensus has emerged for liver diseases that were
previously known as non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction …

The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation

K Smith, KMJH Dennis, L Hodson - Experimental Physiology, 2024 - Wiley Online Library
In health, the liver is a metabolically flexible organ that plays a key role in regulating
systemic lipid and glucose concentrations. There is a constant flux of fatty acids (FAs) to the …

Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease

W Zhang, WJ Song, W Chen, Z Pan… - European Journal of …, 2024 - journals.lww.com
Metabolic dysfunction-associated steatotic liver disease (MASLD)(previously called
nonalcoholic fatty liver disease, NAFLD) is associated with cardiometabolic risk factors and …